The global fallopian tube cancer market is expected to grow at a CAGR of XX% during the forecast period 2016-2021. The market was valued at USD XX million in 2015 and is forecasted to reach USD XX million by 2021.
As per a report by the American Cancer Society, an estimated 22,280 women in the United States are expected be diagnosed with ovarian cancer in 2016, and most of these are high-grade serous ovarian cancers (HGSC), which begin in a fallopian tube. The five-year survival rate for women, with all types of ovarian and fallopian cancer, is 46%. This type of cancer is diagnosed before spreading outside of the tubes in only about 15% of the cases. The survival rate for such cases is almost 90%.
Global Fallopian Tube Cancer - Market Dynamics
The report details several factors driving and restraining the market, some of which are discussed below.
Rise in awareness about the type of cancer and available therapies
Increasing health care expenditure
High cost associated with the surgery and therapy
Adverse side-effects of treatment and toxicity of drugs
The global fallopian tube cancer market has been segmented by type of therapy into surgery (salpingo-oophorectomy and cytoreductive/debulking surgery, among others), chemotherapy and radiation therapy. The drugs that can be used as chemotherapy agents include Taxol (Paclitaxel), Avastin (Bevacizumab), Cisplatin, Evacet (Doxorubicin Hydrochloride Liposome), Doxorubicin Hydrochloride, Gemzar (Gemcitabine Hydrochloride), among multiple others. The market has been geographically segmented into North America, Europe, Asia-Pacific, and Rest of the World.
Some of the key players in the market are:
Boehringer Ingelheim GmbH
Eli Lilly and Company
What the Report Offers
Market definition, along with identification of key drivers and restraints for the market.
Market analysis with region-specific assessments and competition analysis on a global and regional scale.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.
Identification and analysis of the macro and micro factors that affect the industry on both global and regional scale.
A comprehensive list of key market players, along with the analysis of their current strategic interests and key financial information.
An ideal source material for industry consultants, manufacturers and other interested and allied parties to gain critical insight into the factors driving and restraining the market, in addition to opportunities, offered.
PDF E-mail From Publisher
Multi User License (2-5 Users) Fulfilled by Publisher